Clinicopathologic features of patients with hepatocellular carcinoma surviving >10 years after hepatic resection

Cancer

Volumn 83, Issue 11, 1998, Pages 2312-2316

  Shirabe, Ken ^a   Shimada, Mitsuo ^a   Kajiyama, Kiyoshi ^a   Gion, Tomonobu ^a   Ikeda, Yasuharu ^a   Hasegawa, Hirofumi ^a   Taguchi, Kenichi ^a   Takenaka, Kenji ^a   Sugimachi, Keizo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Clinicopathologic features; Hepatic resection; Hepatitis C virus; Hepatocellular carcinoma; Survivors

Indexed keywords

ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VIRUS CARCINOGENESIS;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; JAPAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0032403476     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19981201)83:11<2312::AID-CNCR10>3.0.CO;2-6     Document Type: Article

References (31)

1. Okuda K. Early recognition of hepatocellular carcinoma. Hepatology 1986;6:729-38.
2. The liver cancer study group of Japan. Primary liver cancer in Japan: clinico-pathologic features and results of surgical treatment. Ann Surg 1990;211:277-87.
3. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology 1992;16:948-63.
4. Sakon M, Monden M, Gotoh M. Relationship between pathologic prognostic factors and abnormal levels of des-γy-carboxyprothrombin and a-fetoprotein. Am J Surg 1992;163: 251-6.
5. Shirabe K, Kanematsu T, Matsumata T, Adachi E, Akazawa K, Sugimachi K. Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. Hepatology 1991;14:802-5.
6. Shirabe K, Takenaka K, Taketomi A, Kawahara N, Yamamoto K, Shimada M, et al. Postoperative hepatitis status as a significant risk factor for recurrence in cirrhotic patients with small hepatocellular carcinoma. Cancer 1996;77: 1050-5.
7. Yamanaka N, Okamoto E, Toyosaka A, Mitunobu M, Fujiwara S, Kato T, et al. Prognostic factors after hepatectomy for hepatocellular carcinoma. Cancer 1990;65:1104-10.
8. Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 1991;214:114-7.
9. Lai ECS, Ng IOL, Ng MMT, Lok ASF, Tam PC, Fan ST, et al. Long-term results of resection for large hepatocellular carcinoma: a multivariate analysis of clinico-pathological features. Hepatology 1990;11:815-8.
10. Tang ZY, Yu YQ, Zhou XD, et al. Analysis of one hundred and twenty five patients with primary liver cancer surviving more than five years [English abstract]. Jpn J Cancer Chemother 1992;19:1202-6.
11. Gretch D, dela Rosa D, Carithers R, Willson R, Williams B, Corey L. Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications. Ann Intern Med 1995;123:321-9.
12. Makuuchi M, Hasegawa H, Yamazaki S, Takayasu K, Morinaga N. The use of operative ultrasound as an aid to liver resection in patients with hepatocellular carcinoma. World J Surg 1987;11:615-21.
13. Matsumata T, Kanematsu T, Shirabe K, Sonoda T, Furuta T, Sugimachi K. Decreased morbidity and mortality rates in surgical patients with hepatocellular carcinoma. Br J Surg 1990;77:677-80.
14. Adachi E, Maeda T, Matsumata T, Shirabe K, Kinukawa N, Sugimachi K, et al. Risk factors for intrahepatic in human hepatocellular carcinoma. Gastroenterology 1995;108:768-75.
15. Ikeda K, Saitoh S, Koide I, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993;18:47-53.
16. Takenaka K, Yamamoto K, Taketomi A, Itasaka H, Adachi E, Shirabe K, et al. A comparison of the surgical results in patients with hepatitis versus hepatitis C-related hepatocellular carcinoma. Hepatology 1995;XX:20-4.
17. Eguchi A, Nakashima O, Okudaira S, Sugihara S, Kojiro M. Adenomatous hyperplasia in the vicinity of small hepatocellular carcinoma. Hepatology 1992;15:843-8.
18. Takenaka K, Adachi E, Nishizaki T, et al. Possible multicentric occurrence of hepatocellular carcinoma: a clinicopathological study. Hepatology 1994;19:889-94.
19. Gordon SC, Vallistaram PK, Silverman AL, Dmuchowski CF, Urdea MS, Chan CS, et al. Levels of hepatitis C virus RNA and liver histology in chronic type C hepatitis. Am J Gastroenterol 1994;89:1458-61.
20. Kato N, Hosoda K, Ito Y, Ohto M, Omata M. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease. Hepatology 1993;18:16-20.
21. Lok ASF, Gunarathan NT. Diagnosis of hepatitis C. Hepatology 1997;26(Suppl 1):48S-56.
22. Mazzella G, Accogli E, Sottili S, Festi D, Drsini M, Salzetta A, et al. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis. J Hepatol 1996;24: 141-7.
23. Ko S, Nakajima Y, Kanehiro H, Hisanaga M, Aomatsu Y, Kin T, et al. Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Results of multivariate analysis. Ann Surg 1996;24:591-5.
24. Tarao K, Tekemiya S, Tamai S, Sugimasa Y, Ohkawa S, Akaike M, et al. Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine amino-transferase levels in hepatectomized patients with hepatitis C virus associated cirrhosis and HCC. Cancer 1997;79:688-94.
25. Shimada M, Matsumata T, Taketomi A, Yamamoto K, Itasaka H, Sugimachi K. Repeat hepatectomy for recurrent hepatocellular carcinoma. Surgery 1994;115:703-6.
26. Nagasue N, Yukaya H, Ogawa Y, Sasaki Y, Chang YC, Niimi K. Second hepatic resection for recurrent hepatocellular carcinoma. Br J Surg 1986;73:434-8.
27. Matsuda Y, Ito T, Oguchi Y, Nakajima K, Izukura T. Rationale of surgical management for recurrent hepatocellular carcinoma. Ann Surg 1993;217:28-34.
28. Lange JF, Leese T, Casaing D, Bismuth H. Repeat hepatectomy for recurrent malignant tumor of the liver. Surg Gynecol Obstet 1990;171:398-402.
29. Kanematsu T, Furuta T, Takenaka K, et al. A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology 1989;10:98-102.
30. Furuta T, Kanematsu T, Matsumata T, et al. Lipiodolization prolongs survival rates in postoperative patients with a recurrent hepatocellular carcinoma. Hepatogastroenterology 1990;37:494-7.
31. Shimada M, Takenaka K, Fujiwara Y, et al. Characteristics of hepatocellular carcinoma associated with extrahepatic malignancies in southern Japan. Am J Gastorenterol 1996;91: 754-8.